Crossmark

Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy

Crossref DOI link: https://doi.org/10.1186/s12920-019-0596-2

Published Online: 2019-10-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shao, Jun

Zhang, Yunbin

Fan, Guangming

Xin, Yu

Yao, Yong
Funding

Funding for this research was provided by:

Jiangsu Young Medical Talent (QNRC2016182)

Natural Science Foundation of Jiangsu Province (BK20160053)

National Natural Science Foundation of China (81970819)
License Information

Text and Data Mining valid from 2019-10-15

Version of Record valid from 2019-10-15
More Information

Article History

Received: 19 December 2018

Accepted: 27 September 2019

First Online: 15 October 2019

Ethics approval and consent to participate

: Informed consents were signed for all enrolled patients and healthy individuals. This study followed the tenets of the Declaration of Helsinki and the ARVO statement for research involving human subjects and was approved by the Ethics Committee of Nanjing Medical University (2014–62).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below